Despite its potential benefits, PrecisionTox faces several challenges. One major hurdle is the integration and interpretation of vast amounts of data generated by genomic and computational analyses. Ensuring data quality and reproducibility remains a significant concern, as does the need for standardized methodologies across different research groups. Additionally, there is a need for improved regulatory frameworks that can accommodate and validate the findings from PrecisionTox studies. Addressing these challenges requires collaboration among scientists, regulators, and industry stakeholders.
